India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
Why in the News? Anti-Retroviral Therapy (ART) remains crucial in HIV management, reducing viral load and preventing transmission. Recent medical advancements have improved ART effectiveness, enhancing patient outcomes. Global health initiatives continue to promote ART accessibility to control the HIV epidemic. What is Anti-Retroviral Therapy (ART)? ART is a combination of medications used to manage …
Read MoreWhy in the news? A study by ICMR-NITVAR and Mizoram University highlights the success of HIV self-testing (HIVST) in Mizoram, India’s highest HIV-prevalence state. The initiative helped 84% first-time testers, improving early detection and access to anti-retroviral therapy (ART). HIV Burden in Mizoram: India has an estimated 44 lakh people living with HIV. Mizoram has …
Read MoreWhy the news? World Cancer Day, observed annually on February 4, focuses on raising global awareness about cancer, promoting prevention, and highlighting recent breakthroughs in diagnosis and treatment to improve survival rates and quality of life for patients. Awareness and Prevention: Healthy Lifestyle: Balanced diet, regular exercise, avoiding tobacco and alcohol. Vaccination: Protect against HPV …
Read MoreWhy in the news? Indian scientists have made significant advancements in using gene therapy to treat Haemophilia A, a rare blood disorder. This breakthrough offers long-term relief by addressing the genetic cause, improving quality of life for affected individuals. About Gene Therapy Breakthrough for Haemophilia A in India: Indian scientists have achieved significant progress in …
Read MoreSyllabus: GS-2: Health , Government Policies & Interventions , Important International Institutions Why in the news? India has launched a transformative 100-day campaign across 347 high-burden districts to eliminate tuberculosis (TB). This initiative aims to accelerate early diagnosis, treatment, and nutritional support, reflecting the country’s commitment to achieving the 2025 TB elimination target under Prime …
Read MoreWhy in the news? A new study suggests that semaglutide, a drug for type 2 diabetes and weight loss, may significantly reduce Alzheimer’s risk. This potential breakthrough offers a novel approach to dementia prevention alongside diabetes management, especially for high-risk populations. Study Overview and Findings: Semaglutide, the active ingredient in popular drugs for type 2 …
Read More
